References
- WOMAN trial collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105-2116.
- McNeil DG. Inexpensive drug prevents deaths in new mothers, study finds. The New York Times. Apr 26, 2017. Accessed Nov. 21, 2019.
- CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713-1723.
- Davis N. Common drug could prevent thousands of head injury deaths. The Guardian. Oct. 14, 2019. Accessed Nov. 21, 2019.
- Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
- Sprigg N, Flaherty K, Appleton JP, et al. Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107-2115.
Explore This Issue
ACEP Now: Vol 38 – No 12 – December 2019Pages: 1 2 3 | Single Page
No Responses to “What the Data Say about TXA as for Trauma”